ARTICLE | Company News
BioAlliance, SpePharm sales and marketing update
July 14, 2008 7:00 AM UTC
BioAlliance launched Loramyc miconazole to treat oropharyngeal candidiasis in immunocompromised patients in the U.K., Germany and Denmark. The extended-release, bioadhesive antifungal buccal tablet w...